About
Team
Blog
Approach
Gene Circuit Technology Platform
Allogeneic NK Cells
Scientific Publications
Pipeline
Partnering
News
Careers
Contact
News
Press Releases
|
In the News
All
2021
2020
2019
2018
Senti Bio CEO Appointed to The Alliance for Regenerative Medicine 2022 Board of Directors
10/21/2021
Senti Bio Awarded Funding from National Cancer Institute (NCI) to Support Development of Logic Gated Allogeneic CAR-NK Cell Therapy SENTI-202 to Treat Acute Myeloid Leukemia
09/28/2021
Senti Bio Adds Prominent Scientific and Industry Leaders to its Scientific Advisory Board
08/17/2021
Senti Bio Signs Lease Agreement and Begins Design of Clinical and Commercial-Scale Manufacturing Facility for Allogeneic CAR-NK Cell Therapies
06/15/2021
Senti Bio and BlueRock Therapeutics Enter Collaboration to Develop Gene Circuit-Engineered Cell Therapies for Regenerative Medicine
05/26/2021
Senti Bio to Present Data from CAR-NK Cell Oncology Pipeline at ISCT Annual Meeting
05/25/2021
Senti Bio Announces Key Leadership Appointments
05/19/2021
Senti Bio to Present Data from CAR-NK Cell Oncology Pipeline at ASGCT 24th Annual Meeting
05/11/2021
Senti Bio to Present Data from CAR-NK Cell Oncology Pipeline at Upcoming Scientific Conferences
04/21/2021
Senti Bio Enters Collaboration with Spark Therapeutics to Develop Next-Generation Precision Gene Therapies
04/13/2021
1
(current)
2
